Clinical manifestations of neurological involvement in primary Sjögren’s syndrome.
The aim of this study was to evaluate neurological manifestations of primary Sjögren’s syndrome (pSS) and investigate the etiology and pathogenesis of peripheral and central nervous complications in pSS. Thirty-two patients with pSS were enrolled in the present study, 20 of whom had neurological involvement plus sicca symptoms. The clinical features were evaluated by neurological examinations including nerve conduction study, magnetic resonance imaging, cerebrospinal fluid, and electroencephalogram. The frequency of fever was significantly higher (P = 0.006) in pSS with neurological involvement than in pSS without neurological involvement. There was no statistical significance in other factors between the two groups. Peripheral nervous system (PNS), central nervous system (CNS), and both PNS and CNS involvements were revealed in 14, 3, and 3 patients, respectively. Optic neuritis and trigeminal neuralgia were revealed frequently in cranial neuropathy. Anti-aquaporin 4 antibody was detected in one patient with optic neuritis. Of the nine patients with polyneuropathy, eight patients presented pure sensory neuropathy including small fiber neuropathy (SFN). pSS with SFN appeared to have no clinically abnormal features, including muscle weakness and decreasing deep tendon reflex. Skin biopsy revealed epidermal nerve fiber degenerated in one pSS patient with pure sensory neuropathy who was diagnosed as having SFN. Our observations suggest that a number of mechanisms can be attributed to neurological involvements in pSS rather than just the mechanisms previously described (i.e., vasculitis and ganglioneuronitis). Presumably, specific autoantibodies may directly induce injury of the nervous system.
Gono
Takahisa
T
Institute of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada-cho, Shinjuku-Ku Tokyo 162-0054, Japan.
Kawaguchi
Yasushi
Y
Katsumata
Yasuhiro
Y
Takagi
Kae
K
Tochimoto
Akiko
A
Baba
Sayumi
S
Okamoto
Yuko
Y
Ota
Yuko
Y
Yamanaka
Hisashi
H
D000328:Adult; D002493:Central Nervous System Diseases / Q000145:classification / Q000209:etiology* / Q000503:physiopathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010523:Peripheral Nervous System Diseases / Q000145:classification / Q000209:etiology* / Q000503:physiopathology; D012189:Retrospective Studies; D012859:Sjogren's Syndrome / Q000150:complications* / Q000503:physiopathology
Medicine (Baltimore). 1982 Jul;61(4):247-57
6283302
Neurology. 1999 Sep 22;53(5):1107-14
10496275
Arch Neurol. 1998 Dec;55(12):1513-20
9865794
Brain. 2005 Nov;128(Pt 11):2518-34
16049042
Ann Neurol. 1990 Mar;27(3):304-15
2327738
Lancet Neurol. 2007 Sep;6(9):805-15
17706564
Muscle Nerve. 2006 May;33(5):672-6
16453296
Neurology. 1993 Dec;43(12):2574-81
8255460
Ann Med Interne (Paris). 1995;146(4):235-8
7653942
Ann Rheum Dis. 2002 Jun;61(6):554-8
12006334
Arthritis Rheum. 2000 Jul;43(7):1647-54
10902771
Neurology. 1994 May;44(5):899-908
8190294
Neurology. 1989 Mar;39(3):390-4
2538774
Ann Intern Med. 1986 Mar;104(3):323-30
3946977
Brain. 1987 Dec;110 ( Pt 6):1463-85
3427397
Int Immunopharmacol. 2007 Dec 5;7(12):1535-43
17920530
J Neurol Sci. 2004 Dec 15;227(1):119-30
15546602
Mod Rheumatol. 2009;19(4):437-40
19458906
Brain. 2007 May;130(Pt 5):1235-43
17449477
Medicine (Baltimore). 2004 Sep;83(5):280-291
15342972
J Neurol Sci. 1995 Oct;132(2):122-5
8543935
Hum Immunol. 2005 Apr;66(4):411-6
15866705
Neurology. 2005 Sep 27;65(6):925-7
16186536
Arch Neurol. 2006 Oct;63(10):1410-3
17030656
J Neurol. 2007 Jun;254(6):806-7
17417743
Neurologist. 2002 Jul;8(4):237-53
12803683